Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$63.15 - $71.6 $81.8 Million - $92.8 Million
-1,296,120 Reduced 31.0%
2,884,831 $200 Million
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $39.1 Million - $50.8 Million
720,889 Added 20.83%
4,180,951 $283 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $177 Million - $452 Million
3,329,912 Added 2558.52%
3,460,062 $190 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $7.71 Million - $9.26 Million
130,150 New
130,150 $8.6 Million
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $8.05 Million - $10 Million
-166,155 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$47.16 - $54.44 $292 Million - $337 Million
-6,181,494 Reduced 97.38%
166,155 $8.26 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $25.5 Million - $30.5 Million
525,113 Added 9.02%
6,347,649 $317 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $11 Million - $12.6 Million
-206,649 Reduced 3.43%
5,822,536 $319 Million
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $12.3 Million - $15.8 Million
-285,811 Reduced 4.53%
6,029,185 $319 Million
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $26.7 Million - $36.3 Million
707,496 Added 12.62%
6,314,996 $282 Million
Q4 2019

Feb 13, 2020

SELL
$42.46 - $50.46 $40.5 Million - $48.2 Million
-954,301 Reduced 14.54%
5,607,500 $280 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $17.1 Million - $19.4 Million
426,457 Added 6.95%
6,561,801 $292 Million
Q2 2019

Aug 12, 2019

SELL
$37.28 - $41.68 $4.35 Million - $4.87 Million
-116,802 Reduced 1.87%
6,135,344 $253 Million
Q1 2019

May 14, 2019

BUY
$35.49 - $43.02 $222 Million - $269 Million
6,252,146 New
6,252,146 $253 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.